Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)

Market Cap	65.64B -7.1%
Revenue (ttm)	327.45B +4.4%
Net Income	6.60B +33.8%
EPS	1.78 +33.6%
Shares Out	n/a
PE Ratio	9.94
Forward PE	12.62
Dividend	0.54 (4.48%)
Ex-Dividend Date	Jul 15, 2026

Volume	1,516,000
Open	12.02
Previous Close	12.02
Day's Range	11.84 - 12.02
52-Week Range	10.96 - 13.12
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About HKG:2607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1994
• Employees: 49,608
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2607

Financial Performance

In 2025, HKG:2607's revenue was 283.58 billion, an increase of 3.03% compared to the previous year's 275.25 billion. Earnings were 5.72 billion, an increase of 25.74%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error